{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T06:05:30Z","timestamp":1790661930324,"version":"4.1.0"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T00:00:00Z","timestamp":1790640000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Accurate estimation of SARS-CoV-2 transmission was limited in many settings by incomplete diagnostic testing and case reporting. We conducted a population-based cross-sectional serosurvey in seven regions of Uzbekistan between May and July 2022 to estimate SARS-CoV-2 seroprevalence, describe self-reported vaccination coverage, and assess the implications for routine surveillance. A two-stage cluster sampling design was used to randomly select polyclinic catchment areas and registered residents aged \u22655\u202fyears. Survey weights accounted for selection probabilities, non-response, and regional population structure. Among 15,000 invited individuals, 13,173 completed both questionnaire and serological testing, corresponding to an 87.8% response rate. Weighted seroprevalence was 98.3% (95% CI 98.0\u201398.6), indicating extensive cumulative exposure through infection, vaccination, or both. Self-reported vaccination coverage was 59.0% among adults and substantially lower among children. Approximately 243,000 COVID-19 cases had been officially reported nationally by August 2022; however, this national count is not directly comparable with seroprevalence in the seven surveyed regions. Nevertheless, the high seroprevalence, including among groups with low vaccination coverage, is suggestive of substantial transmission not identified by routine case reporting. Population-based serosurveys can therefore complement routine surveillance when interpreted alongside vaccination and epidemiological data.<\/jats:p>","DOI":"10.3389\/fpubh.2026.1821072","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:50:11Z","timestamp":1790661011000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["SARS-CoV-2 seroprevalence and extent of infection under-ascertainment in seven regions of Uzbekistan: a population-based serosurvey, May\u2013July 2022"],"prefix":"10.3389","volume":"14","author":[{"given":"Aybek","family":"Khodiev","sequence":"first","affiliation":[{"name":"CDC Uzbekistan Country Office","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander J.","family":"Millman","sequence":"additional","affiliation":[{"name":"CDC Central Asia Regional Office","place":["Almaty, Kazakhstan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Botirjon","family":"Kurbanov","sequence":"additional","affiliation":[{"name":"Committee for Sanitary and Epidemiological Welfare and Public Health, Ministry of Health of the Republic of Uzbekistan","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Carter","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Sloan","sequence":"additional","affiliation":[{"name":"National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention","place":["Atlanta, GA, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zulfiya","family":"Abdurakhimova","sequence":"additional","affiliation":[{"name":"Committee for Sanitary and Epidemiological Welfare and Public Health, Ministry of Health of the Republic of Uzbekistan","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shakhida","family":"Karamatova","sequence":"additional","affiliation":[{"name":"CDC Uzbekistan Country Office","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adkhamjon","family":"Mamatkulov","sequence":"additional","affiliation":[{"name":"Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizaveta","family":"Joldasova","sequence":"additional","affiliation":[{"name":"Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dilafkor","family":"Mirdjalilov","sequence":"additional","affiliation":[{"name":"CDC Uzbekistan Country Office","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leyla","family":"Koroli","sequence":"additional","affiliation":[{"name":"CDC Uzbekistan Country Office","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nataliya","family":"Kan","sequence":"additional","affiliation":[{"name":"Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulaziz","family":"Abdurasulov","sequence":"additional","affiliation":[{"name":"Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erkin","family":"Musabaev","sequence":"additional","affiliation":[{"name":"Research Institute of Virology, Ministry of Health of the Republic of Uzbekistan","place":["Tashkent, Uzbekistan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,29]]},"reference":[{"key":"ref1","volume-title":"WHO COVID-19 Dashboard","year":"2025"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12961-023-00963-1","article-title":"Limitations of COVID-19 testing and case data for evidence-informed health policy and practice","volume":"21","author":"Alvarez","year":"2023","journal-title":"Health Res Policy Syst"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"103593","DOI":"10.1016\/j.cities.2022.103593","article-title":"Exploring the impact of under-reported cases on the COVID-19 spatiotemporal distributions using healthcare workers infection data","volume":"123","author":"Wang","year":"2022","journal-title":"Cities"},{"key":"ref4","year":"2025"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/s0140-6736(16)30164-7","article-title":"Use of serological surveys to generate key insights into the changing global landscape of infectious disease","volume":"388","author":"Metcalf","year":"2016","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"e559","DOI":"10.1016\/S2214-109X(21)00057-7","article-title":"COVID-19 serosurveys for public health decision making","volume":"9","author":"Murhekar","year":"2021","journal-title":"Lancet Glob Health"},{"key":"ref7","first-page":"5","article-title":"Formation of herd immunity to SARS-CoV-2 in the regions of Uzbekistan","volume":"8","author":"Rakhimov","year":"2021","journal-title":"Eur J Mol Clin Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1111\/irv.12915","article-title":"Early epidemiological investigations: World Health Organization UNITY protocols provide a standardized and timely international investigation framework during the COVID-19 pandemic","volume":"16","author":"Bergeri","year":"2022","journal-title":"Influenza Other Respir Viruses"},{"key":"ref9","first-page":"9","article-title":"Practical issues in calculating the sample size for prevalence studies","volume":"9","author":"Naing","year":"2006","journal-title":"Arch Orofac Sci"},{"key":"ref10","volume-title":"Sampling of Populations: Methods and Applications","author":"Levy","year":"2013"},{"key":"ref11","year":"2025"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v009.i08","article-title":"Analysis of complex survey samples","volume":"9","author":"Lumley","year":"2004","journal-title":"J Stat Softw"},{"key":"ref13","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-4612-0795-5","volume-title":"The Jackknife and Bootstrap","author":"Shao","year":"1995"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.32614\/rj-2021-053","article-title":"Reproducible summary tables with the gtsummary package","volume":"13","author":"Sjoberg","year":"2021","journal-title":"R J"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3201\/eid2906.221862","article-title":"High prevalence of SARS-CoV-2 omicron infection despite high seroprevalence, Sweden, 2022","volume":"29","author":"Groenheit","year":"2023","journal-title":"Emerg Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"100760","DOI":"10.1016\/j.lanwpc.2023.100760","article-title":"SARS-CoV-2 seroepidemiology in Mongolia, 2020-2021: a longitudinal national study","volume":"36","author":"Chimeddorj","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"100390","DOI":"10.1016\/j.lana.2022.100390","article-title":"SARS-CoV-2 seroprevalence, cumulative infections, and immunity to symptomatic infection - a multistage national household survey and modelling study, Dominican Republic, June-October 2021","volume":"16","author":"Nilles","year":"2021","journal-title":"Lancet Reg Health Am"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e75","DOI":"10.1016\/S1473-3099(20)30631-9","article-title":"SeroTracker: a global SARS-CoV-2 seroprevalence dashboard","volume":"21","author":"Arora","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.pulmoe.2020.05.015","article-title":"Evaluating the massive underreporting and undertesting of COVID-19 cases in multiple global epicenters","volume":"27","author":"Lau","year":"2021","journal-title":"Pulmonology"},{"key":"ref20","author":"Mathieu","year":"2020"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s40121-024-01081-3","article-title":"A narrative review of key risk factors for severe illness following SARS-CoV-2, influenza virus, and respiratory syncytial virus infection","volume":"14","author":"Branche","year":"2025","journal-title":"Infect Dis Ther"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2162301","DOI":"10.1080\/21645515.2022.2162301","article-title":"Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: a retrospective cohort study in Italy","volume":"19","author":"Bianchi","year":"2023","journal-title":"Hum Vaccin Immunother"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"4057","DOI":"10.1016\/j.vaccine.2023.04.047","article-title":"Prevalence of poliovirus neutralizing antibodies in Italian population: a systematic review and meta-analysis","volume":"41","author":"Tafuri","year":"2023","journal-title":"Vaccine"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1821072\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:50:13Z","timestamp":1790661013000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1821072\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,29]]},"references-count":23,"alternative-id":["10.3389\/fpubh.2026.1821072"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1821072","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,29]]},"article-number":"1821072"}}